Descovy Mechanism Of Action
By blocking reverse transcriptase Descovy reduces the amount of HIV in the blood and keeps it at a low level. Its used for two purposes. Descovy Emtricitabine Tenofovir Alafenamide For The Treatment Of Hiv 1 Infection Clinical Trials Arena Emtricitabine is a nucleoside reverse transcriptase inhibitor NRTI and nucleoside analogue of 2-deoxycytidine. Descovy mechanism of action . DESCOVY is indicated in at-risk adults and adolescents weighing at least 35 kg for pre-exposure prophylaxis PrEP to reduce the risk of HIV-1 infection from sexual acquisition excluding individuals at risk from receptive vaginal sex. It is a conjugate base of a tenofovir alafenamide 1. It derives from an adenine. It is a L-alanine derivative a phosphoramidate ester an ether a member of 6-aminopurines and an isopropyl ester. Emtricitabine is also marketed in a fixed-dose combination with tenofovir disoproxil under the brand name Truvada and with tenofovir alafenamide under the brand name Descovy. DESC